By Catherine Eckford2025-12-09T16:10:00
EpiVax and Cubrc research supports FDA guidance on impurity risk assessment in generic peptides.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-21T08:24:00Z
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-05-12T07:43:00
Sponsored by Sartorius, By European Pharmaceutical Review
2025-11-05T15:00:00
Sponsored by FUJIFILM Wako Pure Chemical Corporation
2025-06-03T13:35:00
Sponsored by bioMérieux, By European Pharmaceutical Review
Site powered by Webvision Cloud